- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02091726
Phase 4 Field Trial of the Unicirc Instrument With Tissue Adhesive (Unicirc003)
September 4, 2018 updated by: Peter Millard, Simunye Primary Health Care
This is a field trial of the Unicirc instrument to excise the foreskin, plus use of cyanoacrylate tissue adhesive to seal the wound.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
110
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Western Cape
-
Cape Town, Western Cape, South Africa
- Simunye Primary Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 99 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Men at least 18 years of age
Exclusion Criteria:
- Poor general health
- Anatomical abnormalities that would complicate circumcision
- Bleeding disorder
- Ongoing infection
- Cannot attend followup visits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Unicirc with tissue adhesive
Circumcision with Unicirc instrument, followed by wound sealing with cyanoacrylate
|
Volunteers will be circumcised using the Unicirc surgical instrument and the incision will be sealed using cyanoacrylate tissue adhesive
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time for Procedure
Time Frame: 1 hour
|
Intraoperative time, total
|
1 hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completely Healed at 4 Weeks
Time Frame: 4 weeks
|
Definition: Completely epithelialized; no superficial ulcerations or granulation tissue present
|
4 weeks
|
|
Wound Separation
Time Frame: 4 weeks
|
Wound separation caused by adhesive failure (minor --requires no treatment)
|
4 weeks
|
|
Cosmetic Result Excellent
Time Frame: 4 weeks
|
Excellent: scar line straight without any irregularity Irregular: Some irregularity to scar line Scalloped: wavy appearane to scar line
|
4 weeks
|
|
Participant Fully Satisfied and Would Recommend to Friends and Family
Time Frame: 4 weeks
|
Yes to both of the following questions: Are you fully satisfied with your circumcision result?
Would you recommend circumcision to friends or family?
|
4 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Norman Goldstuck, MD, Department of Obstetrics and Gynaecology, Tygerberg Hospital, Cape Town, South Africa
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
March 14, 2014
First Submitted That Met QC Criteria
March 17, 2014
First Posted (Estimate)
March 19, 2014
Study Record Updates
Last Update Posted (Actual)
September 6, 2018
Last Update Submitted That Met QC Criteria
September 4, 2018
Last Verified
September 1, 2018
More Information
Terms related to this study
Other Study ID Numbers
- Unicirc 003
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Male Circumcision
-
ProgressusUnknownCircumcision, Male | Circumcision Status: Circumcised, Uncircumcised
-
University of North Carolina, Chapel HillBill and Melinda Gates Foundation; FHI 360; Impact Research & Development OrganizationCompletedVoluntary Medical Male Circumcision | Circumcision AdultKenya
-
Weill Medical College of Cornell UniversityBill and Melinda Gates FoundationCompleted
-
King Saud UniversityUnknownCircumcision, MaleSaudi Arabia
-
Medical University of South CarolinaCompleted
-
Simunye Primary Health CareCompleted
-
Kocatepe UniversityCompleted
-
FHI 360Weill Medical College of Cornell University; Bill and Melinda Gates Foundation and other collaboratorsCompletedMale CircumcisionKenya, Zambia
-
ProgressusUnknownMale | CircumcisionZambia
Clinical Trials on Unicirc instrument plus cyanoacrylate tissue adhesive
-
Simunye Primary Health CareCompleted
-
Cairo UniversityUnknownSoft Tissue Atrophy
-
Simunye Primary Health CareCompleted
-
University of Medicine and Pharmacy at Ho Chi Minh...Not yet recruitingImpacted Mandibular Third Molar
-
Brno University HospitalRecruitingApical Prolapse | Sacrocolpopexy | Glue FixationCzechia
-
Simunye Primary Health CareCompleted
-
The University of Texas Health Science Center,...TerminatedEyelid LacerationUnited States
-
Indiana UniversityCompleted
-
Mayo ClinicTerminatedCardiovascular DiseaseUnited States
-
Minia UniversityRecruitingPancreatic Fistula | Pancreatic Ductal Adenocarcinoma | Pancreas Cancer | Periampullary CarcinomaEgypt